NISHIO; Kazuto

Patent Applications and Registrations

Patent applications and USPTO patent grants for NISHIO; Kazuto.The latest application filed is for "method of using a ret fusion gene as a biomarker to select non small cell lung cancer (nsclc) and thyroid cancer patients for a cancer treatment".

Company Profile

1.6.10

NISHIO; Kazuto - Osakasayama-shi JP
NISHIO; Kazuto - Osaka JP
Nishio; Kazuto - Osakasayama JP
Nishio; Kazuto - Tokyo JP
Nishio; Kazuto - Chiba JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method Of Using A Ret Fusion Gene As A Biomarker To Select Non Small Cell Lung Cancer (nsclc) And Thyroid Cancer Patients For A Cancer Treatment App 20190002988 - HAYASHI; Hidetoshi ; et al.	2019-01-03
Treatment Selection Method And Biomarker Indicating Selection App 20180285521 - NISHIO; Kazuto ; et al.	2018-10-04
Method or system using biomarkers for the monitoring of a treatment Grant 8,802,384 - Arao , et al. August 12, 2	2014-08-12
Cell Analysis Device App 20130314526 - Yasuda; Kenji ; et al.	2013-11-28
Risk Prediction Of Developing Drug-induced Lung Injury And Detection Method And Kit Of Gene For Risk Prediction App 20130085081 - Koizumi; Fumiaki ; et al.	2013-04-04
Method of diagnosing pancreatic cancer with the use of N-binding type sugar chains Grant 8,372,647 - Arao , et al. February 12, 2	2013-02-12
Rotaxane compound and antitumor agent Grant 8,207,357 - Takata , et al. June 26, 2	2012-06-26
Rotaxane Compound And Antitumor Agent App 20110237807 - Takata; Toshikazu ; et al.	2011-09-29
Method of Diagnosing Pancreatic Cancer with the Use of N-Binding Type Sugar Chains App 20110065141 - Arao; Tokuzo ; et al.	2011-03-17
Method Or System Using Biomarkers For The Monitoring Of A Treatment App 20100233705 - ARAO; Tokuzo ; et al.	2010-09-16
Method to predict or monitor the response of a patient to an erbb receptor drug App 20080286785 - Nishio; Kazuto ; et al.	2008-11-20
Anticancer agents Grant 6,683,083 - Kaneko , et al. January 27, 2	2004-01-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.